Three presentations at ADA 2025 highlighted the therapeutic potential of icovamenib across multiple aspects of metabolic health:In patients with type 2 diabetes (T2D) not achieving glycemic targets, ...

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Euronext, the leading European capital market infrastructure, today announces the submission of an all-share voluntary share exchange offer (the ‘Offer’) addressed to all shareholders of HELLENIC ...

Euronext to launch voluntary share exchange offer for all ATHEX shares Euronext announces the submission of a voluntary share ...